Publications by authors named "O I Barygin"

Amidine-containing compounds are primarily known as antiprotozoal agents (pentamidine, diminazene, furamidine) or as serine protease inhibitors (nafamostat, sepimostat, camostat, gabexate). DAPI is widely recognized as a fluorescent DNA stain. Recently, it has been shown that these compounds also act as NMDA receptor inhibitors.

View Article and Find Full Text PDF
Article Synopsis
  • - Recent research highlights the repurposing of NMDA receptor antagonists like ketamine for treating major depressive disorder, sparking renewed interest in studying NMDA receptors.
  • - A study used whole-cell patch-clamp methods to evaluate the effects of biguanide compounds on NMDA receptors in rat hippocampal neurons, finding that certain compounds like cycloguanil, proguanil, and phenformin effectively inhibited these receptors.
  • - The compounds were found to act as non-competitive inhibitors, with distinct mechanisms, suggesting their potential for treating neurodegenerative disorders linked to glutamatergic excitotoxicity and providing insights into NMDA receptor structure.
View Article and Find Full Text PDF

N-methyl-D-aspartate (NMDA) receptors are inhibited by many amidine and guanidine compounds. In this work, we studied the mechanisms of their inhibition by sepimostat-an amidine-containing serine protease inhibitor with neuroprotective properties. Sepimostat inhibited native NMDA receptors in rat hippocampal CA1 pyramidal neurons with IC of 3.

View Article and Find Full Text PDF

Febrile seizures (FSs) are a relatively common early-life condition that can cause CNS developmental disorders, but the specific mechanisms of action of FS are poorly understood. In this work, we used hyperthermia-induced FS in 10-day-old rats. We demonstrated that the efficiency of glutamatergic synaptic transmission decreased rapidly after FS by recording local field potentials.

View Article and Find Full Text PDF
Article Synopsis
  • Acid-sensing ion channels (ASICs) are inhibited by various cationic compounds, and understanding how these compounds work can help in designing new drugs.
  • In a study on serine protease inhibitors like nafamostat, sepimostat, and diminazene, it was found that they effectively blocked ASICs in rat brain cells, whereas camostat and gabexate showed little to no effect.
  • Nafamostat, sepimostat, and diminazene demonstrated a voltage-dependent inhibition mechanism, suggesting potential for therapeutic use in conditions related to ASIC dysfunction, such as inflammatory pain and ischemic stroke.
View Article and Find Full Text PDF